Pharmafile Logo

Early Pipeline Case Study

- PMLiVE

Brexit fears grow for small-to-medium pharma

New survey from EMIG shows sector struggling with uncertainty

- PMLiVE

Summit plunges after Duchenne disappointment

UK company to abandon lead molecule after phase II trial failure

- PMLiVE

The Communiqué Awards 2018 – the countdown has begun

New categories recognise excellence in Integrated Non-Promotional Communications, and Communication Through Creative Execution.

- PMLiVE

Indefinable, incomparable and enduring: the value of creativity

Building an environment that encourages, nurtures and harnesses creativity

Gilead Sciences

Gilead’s Biktarvy gets European approval, setting up battle with GSK

The drug could offset Gilead's disappointing hep C franchise

- PMLiVE

Plasticell and London’s gene therapy pioneers to tackle manufacturing conundrum

New funding will help London build on its gene therapy expertise

- PMLiVE

Diversity and inclusion in the pharma industry

Is there equality in the workplace?

- PMLiVE

Wilmington Healthcare appoints new Commercial Director

Healthcare intelligence provider Wilmington Healthcare, which incorporates HSJ, Binley’s, OnMedica and Wellards, has appointed Sue Plant as Commercial Director for MedTech.

Wilmington Healthcare

- PMLiVE

US approval for first ever cannabis-based medicine

UK company's Epidiolex tipped to be blockbuster

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links